Lutetium lu 177 dotatate Alternatives Compared
| Lutetium lu 177 dotatate | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|---|
| Lutetium lu 177 dotatate | Lutathera (lutetium lu 177 dotatate) | Lanreotide |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neuroendocrine Tumors. Lutetium lu 177 dotatate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors. Lutathera may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide. |
Related suggestions Neuroendocrine Tumors
|
|||||||||||||||
| More about Lutetium lu 177 dotatate | More about Lutathera (lutetium lu 177 dotatate) | More about Lanreotide | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Lutathera side effects |
View all Lanreotide side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Lutathera prices |
View all Lanreotide prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Lutathera |
N/A |
Somatuline Depot | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
71 hours |
71 hours |
720 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 235 drugs are known to interact with Lutetium lu 177 dotatate:
|
A total of 235 drugs are known to interact with Lutathera:
|
A total of 162 drugs are known to interact with Lanreotide:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.